Diagnostics, Legal & Legislative

Dr. Reddy's Laboratories Ltd. entered into a settlement agreement with Novartis Pharma AG which involves a stipulation of dismissal of the lawsuits in the United States relating to the Abbreviated New Drug Applications filed by Dr. Reddy's for a generic version of rivastigmine tartrate capsules sold under the trade-name Exelon. Under the terms of the agreement, Dr. Reddy's will not launch its generic Rivastigmine Tartrate capsules until sometime before the expiry of the Orange Book patents claiming Rivastigmine.

Dr. Reddy's Laboratories Ltd. entered into a settlement agreement with Novartis Pharma AG which involves a stipulation of dismissal of the lawsuits in the United States relating to the Abbreviated New Drug Applications filed by Dr. Reddy's for a generic version of rivastigmine tartrate capsules sold under the trade-name Exelon. Under the terms of the agreement, Dr. Reddy's will not launch its generic Rivastigmine Tartrate capsules until sometime before the expiry of the Orange Book patents claiming Rivastigmine.

Tissue Extraction Devices, LLC announced that it has filed a patent infringement lawsuit against Hologic Inc. and wholly-owned subsidiary, Suros Surgical Systems Inc. Tissue Extraction Devices strongly believes that many fundamental aspects of Hologic / Suros' ATEC® line of breast biopsy systems infringe Tissue Extraction Devices' U.S. Patent No. 7,316,726. The suit was filed in the United States District Court for the Northern District of Illinois -Eastern Division.

Coughlin Stoia Geller Rudman & Robbins LLP (Coughlin Stoia) announced that a class action has been commenced in the United States District Court for the District of Massachusetts on behalf of purchasers of NeuroMetrix Inc. common stock during the period between October 27, 2005 and March 6, 2007 the class Period.